IDEX (NYSE:IEX) Issues Quarterly Earnings Results

IDEX (NYSE:IEX) announced its quarterly earnings data on Wednesday. The industrial products company reported $2.10 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.04 by $0.06, FiscalAI reports. The business had revenue of $899.10 million during the quarter, compared to analyst estimates of $882.00 million. IDEX had a net margin of 13.97% and a return on equity of 15.20%. The company’s revenue was up 4.2% on a year-over-year basis. During the same period last year, the firm posted $2.04 EPS. IDEX updated its Q1 2026 guidance to 1.730-1.780 EPS and its FY 2026 guidance to 8.150-8.35 EPS.

Here are the key takeaways from IDEX’s conference call:

• IDEX’s Health & Science Technologies (HST) segment showed strong momentum with 34% organic orders growth in Q4, ~$493M in segment orders and broad demand in data-center, semiconductor, space/defense and related applications, giving management higher conviction for HST into 2026.
• The company reported better-than-expected Q4 results with adjusted EBITDA margin +40 bps, an adjusted EPS beat, and strong cash generation — $617M free cash flow for FY‑2025 (103% conversion), ~$1.1B liquidity and ~$250M of share repurchases in 2025.
• 2026 guidance is modestly paced: organic growth 1%–2%, adjusted EBITDA margin targeted at 26.5%–27% and adjusted EPS of $8.15–$8.35, reflecting mid-single-digit HST growth offset by flat-to-down FMT and FSDP.
• Industrial-facing segments remain soft — FMT saw only +4% orders/+1% sales and FSDP had flat orders and -5% sales, with ongoing weakness in chemicals, energy, agriculture and international fire & safety demand and no clear macro inflection yet.
• Capital allocation remains shareholder-friendly and disciplined: focus on tuck‑in M&A (integrating Micro‑LAM), maintaining investment‑grade leverage, a dividend target of 30%–35% of adjusted net income, and a base repurchase cadence (~$75M/quarter assumption).

IDEX Stock Up 3.1%

IDEX stock traded up $6.18 during midday trading on Wednesday, hitting $207.79. 778,666 shares of the company’s stock were exchanged, compared to its average volume of 750,585. IDEX has a 12 month low of $153.36 and a 12 month high of $210.90. The company has a debt-to-equity ratio of 0.47, a quick ratio of 2.06 and a current ratio of 2.93. The company has a market cap of $15.55 billion, a PE ratio of 32.88, a P/E/G ratio of 1.99 and a beta of 1.00. The firm has a 50-day moving average of $184.24 and a two-hundred day moving average of $172.50.

IDEX Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, January 30th. Shareholders of record on Friday, January 16th were issued a dividend of $0.71 per share. This represents a $2.84 annualized dividend and a yield of 1.4%. The ex-dividend date was Friday, January 16th. IDEX’s dividend payout ratio is presently 44.94%.

IDEX News Roundup

Here are the key news stories impacting IDEX this week:

• Positive Sentiment: IDEX beat both top‑line and bottom‑line estimates for Q4 — $2.10 EPS vs. consensus ~ $2.04 and revenue of $899.1M (up ~4.2% YoY) with healthy margins and ROE — signaling continued operational strength. Article Title
• Positive Sentiment: Management released a slide deck and press release alongside results, providing detail on drivers behind the beat (useful for investors assessing sustainability of growth). Press Release / Slides
• Neutral Sentiment: Analysts and outlets are processing the quarter and guidance; some coverage highlights the company’s strong business fundamentals but flags valuation as a consideration. Article Title
• Negative Sentiment: IDEX set Q1 FY26 EPS guidance at $1.73–1.78 (consensus ~ $1.84) and FY26 EPS at $8.15–8.35 (consensus ~ $8.31) — ranges that are modestly below analysts’ expectations and could cap near‑term upside. Article Title

Hedge Funds Weigh In On IDEX

Several institutional investors have recently bought and sold shares of the business. Two Sigma Investments LP boosted its position in IDEX by 446.8% during the 3rd quarter. Two Sigma Investments LP now owns 329,337 shares of the industrial products company’s stock valued at $53,603,000 after acquiring an additional 269,109 shares in the last quarter. Invesco Ltd. lifted its stake in shares of IDEX by 16.1% during the 3rd quarter. Invesco Ltd. now owns 1,809,788 shares of the industrial products company’s stock worth $294,561,000 after purchasing an additional 250,447 shares during the last quarter. Amundi boosted its position in IDEX by 18.7% during the third quarter. Amundi now owns 1,517,903 shares of the industrial products company’s stock valued at $248,751,000 after purchasing an additional 239,215 shares in the last quarter. Squarepoint Ops LLC grew its stake in IDEX by 635.4% in the second quarter. Squarepoint Ops LLC now owns 264,492 shares of the industrial products company’s stock valued at $46,437,000 after purchasing an additional 228,525 shares during the last quarter. Finally, Voloridge Investment Management LLC raised its holdings in IDEX by 82.4% in the third quarter. Voloridge Investment Management LLC now owns 422,936 shares of the industrial products company’s stock worth $68,837,000 after purchasing an additional 191,014 shares in the last quarter. 97.96% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several research analysts have commented on the stock. Oppenheimer set a $210.00 price objective on shares of IDEX in a research note on Tuesday, October 7th. Royal Bank Of Canada restated an “outperform” rating and set a $211.00 target price on shares of IDEX in a research report on Thursday, January 15th. Weiss Ratings reiterated a “hold (c-)” rating on shares of IDEX in a report on Wednesday, October 8th. Citigroup raised their price target on IDEX from $197.00 to $202.00 and gave the stock a “buy” rating in a research note on Monday, December 8th. Finally, TD Cowen reaffirmed a “buy” rating on shares of IDEX in a research report on Wednesday, December 3rd. Five equities research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $203.29.

About IDEX

IDEX Corporation is a diversified industrial manufacturer specializing in the design, production and distribution of highly engineered fluidics systems, measurement technologies and safety solutions. The company’s core offerings include positive-displacement pumps, flow meters, valves, sampling systems and analytical instruments that serve a wide range of end markets such as water treatment, chemical processing, energy, food and beverage, and life sciences. Through its focus on precision engineering and proprietary material science, IDEX delivers products designed for reliability in demanding applications.

Operations at IDEX are organized into three principal segments.